Pfizer News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

02.11.16	PTN Surges On Trial Data, PFE Dumps Cholesterol Drug, Watch Out For PRTA (RTTNews)
01.11.16	Pfizer Q3 Profit Falls; To Discontinue Bococizumab Development Program (RTTNews)
01.11.16	EARNINGS SUMMARY: Details of Pfizer Inc. Q3 Earnings Report (RTTNews)
31.10.16	EMA To Review Merck's Avelumab For Treatment Of Metastatic Merkel Cell Carcinoma (RTTNews)
19.10.16	Pfizer Awarded Grant From Bill & Melinda Gates Foundation - Quick Facts (RTTNews)
18.10.16	Pfizer To Begin Shipment Of Biosimilar INFLECTRA To Wholesalers In Nov (RTTNews)
15.10.16	Pfizer to Present New Data on XELJANZ® (Tofacitinib Citrate) for Ulcerative Colitis at UEG Week 2016 (Businesswire)
10.10.16	Pfizer: Positive Results From SUTENT Trial As Adjuvant Therapy In Renal Cancer (RTTNews)
09.10.16	Pfizer Presents Promising New Immunotherapy Combination Data With INLYTA® (axitinib) In Advanced Renal Cell Carcinoma (RCC) (Businesswire)
06.10.16	ICU Medical To Acquire Pfizer's Hospira In $1 Bln Deal - Quick Facts (RTTNews)
28.09.16	Pfizer Completes Acquisition Of Medivation (RTTNews)
28.09.16	Pfizer to Showcase Progress of Broad-Based Oncology Portfolio at European Society for Medical Oncology (ESMO) 2016 Congress (Businesswire)
26.09.16	Pfizer Says Not To Pursue Splitting Innovative Health, Essential Health Into Two (RTTNews)
23.09.16	Pfizer Gets U.S. Regulatory Approval For Medivation Takeover (RTTNews)
16.09.16	Pfizer Receives Positive CHMP Opinion For IBRANCE (RTTNews)
16.09.16	Pfizer Receives Positive CHMP Opinion For IBRANCE® (palbociclib) In Combination With Endocrine Therapy For The Treatment Of HR+/HER2- Metastatic Breast Cancer In Europe (Businesswire)
15.09.16	OncoImmune Reaches Option And License Agreement With Pfizer (RTTNews)
15.09.16	Merck, Pfizer Announce Ertugliflozin Meets Primary Endpoint In Phase 3 Study (RTTNews)
15.09.16	Data Boosts AERI, FDA Panel Snubs SPPI, D-Day For ACRX Today, VTAE Abuzz (RTTNews)
01.09.16	CYNA Snapped Up For $624 Mln, AMRN On Track, Genmab Gets FDA Nod (RTTNews)
31.08.16	XALKORI® (Crizotinib) Receives Approval In European Union For The Treatment Of Patients With ROS1-Positive Advanced Non-Small Cell Lung Cancer (Businesswire)
25.08.16	HEB Gets Some Respite, ITEK Awaits Data In Dec., NYMX Abuzz, FDA Snubs AMGN (RTTNews)
24.08.16	Pfizer Acquires Rights Of AstraZeneca's Small Molecule Anti-infectives Business (RTTNews)
23.08.16	Jacobs Wins Contract For Pfizer Global Biotechnology Center In China (RTTNews)
23.08.16	BPMX Scores A Facelift, MDVN Says "I Do" To PFE, Europe Gets Its 1st HIV PrEP (RTTNews)
22.08.16	Pfizer To Buy Prostate-cancer Drug Maker Medivation For $14 Bln (RTTNews)
22.08.16	Pfizer To Buy Medivation For Total Enterprise Value Of About $14 Bln (RTTNews)
22.08.16	Pfizer Reportedly Nears $14 Bln Deal To Acquire Medivation (RTTNews)
22.08.16	PFE, SUPN Get FDA Nod, SNY Will Have To Wait Till Nov., Xenetic On The Move (RTTNews)
22.08.16	Pfizer Reportedly Nears Agreement To Buy Medivation For About $14 Bln (RTTNews)
09.08.16	MESO Gains After Hours, PFNX Gets It Back, CHRS' Humira Biosimilar Meets Goals (RTTNews)
08.08.16	Pfizer Announces Publication Of New Data From Studies Of Vyndaqel - Quick Facts (RTTNews)
02.08.16	Pfizer Q2 Profit Beats Estimates; Standalone Revenues Up 4%; Reaffirms Guidance (RTTNews)
02.08.16	Pfizer Inc. Q2 Income Advances 10% (RTTNews)
02.08.16	SMA Data Endears IONS To Investors, PFE Opens Wallet, Busy Months Ahead For DRRX (RTTNews)
01.08.16	Pfizer Buys Bamboo Therapeutics (RTTNews)
28.07.16	Pfizer Reports Positive Top-Line Results From XELJANZ Phase 3 Maintenance Trial (RTTNews)
28.07.16	Pfizer, Western Oncolytics Collaborate To Investigate Novel Oncolytic Virus Tech (RTTNews)
25.07.16	Spark Therapeutics, Pfizer Present Updated Data From Ongoing SPK-9001 Trial (RTTNews)
21.07.16	FDA Grants Breakthrough Therapy Designation For Spark, Pfizer's SPK-9001 (RTTNews)
18.07.16	ARIA Study Shows Efficacy Of Triumeq For Treatment-naïve Women Living With HIV (RTTNews)
13.07.16	Pfizer Announces Publication Of Results On Crisaborole Topical Ointment (RTTNews)
13.07.16	SAGE On A High, JUNO Rockets As FDA Lifts Clinical Hold, FDA Panel Nod For AMGN (RTTNews)
12.07.16	FDA Approves Pfizer's Pneumonia Vaccine For Adults (RTTNews)
11.07.16	Echo Fails The Test, OREX To Effect Reverse Split, PFE's S-TRAC Study Hits Goal (RTTNews)
08.07.16	Pfizer: S-TRAC Trial Results Of SUTENT Meets Primary Endpoint - Quick Facts (RTTNews)
07.07.16	Nanobiotix Takes A Big Step, VRTX Broadens Pipeline, PFE Aims High With Javelin (RTTNews)
06.07.16	Merck, Pfizer Initiate Phase III Trial To Evaluate Avelumab - Quick Facts (RTTNews)
06.07.16	Merck KGaA, Darmstadt, Germany, and Pfizer Initiate Phase III Trial to Evaluate Avelumab as First-line Treatment for Ovarian Cancer (Businesswire)
06.07.16	Merck and Pfizer Initiate Phase III Trial to Evaluate Avelumab as First-line Treatment for Ovarian Cancer (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

11:20		Roche-Aktie verliert: Roche vermeldet Forschungsrückschlag - Mittel verfehlt primären Endpunkt
10:48		Merck-Aktie in Rot: Merck erhöht Kapitalaufwand an japanischem Standort
09:28		Verluste in Zürich: SPI sackt zum Handelsstart ab
09:28		SIX-Handel SLI präsentiert sich zum Handelsstart schwächer
09:28		Börse London: FTSE 100 zum Start in Rot
09:28		Schwache Performance in Zürich: SMI präsentiert sich zum Start des Donnerstagshandels schwächer
18.12.24		Dow Jones-Handel aktuell: Dow Jones beendet den Mittwochshandel mit Verlusten
18.12.24		Börse Zürich in Rot: SPI schliesst in der Verlustzone

11:20

Roche-Aktie verliert: Roche vermeldet Forschungsrückschlag - Mittel verfehlt primären Endpunkt

10:48

Merck-Aktie in Rot: Merck erhöht Kapitalaufwand an japanischem Standort

09:28

Verluste in Zürich: SPI sackt zum Handelsstart ab

09:28

SIX-Handel SLI präsentiert sich zum Handelsstart schwächer

09:28

Börse London: FTSE 100 zum Start in Rot

09:28

Schwache Performance in Zürich: SMI präsentiert sich zum Start des Donnerstagshandels schwächer

18.12.24

Dow Jones-Handel aktuell: Dow Jones beendet den Mittwochshandel mit Verlusten

18.12.24

Börse Zürich in Rot: SPI schliesst in der Verlustzone

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nestle	73.94	-0.22 %	K V
Swiss Life Hldg	686.60	-0.35 %	K V
Novartis	87.65	-0.44 %	K V
Alcon	76.18	-0.57 %	K V
Kuehne+Nagel Int	201.00	-0.64 %	K V
CieFinRichemont	133.50	-2.59 %	K V
Logitech Intl	72.54	-3.05 %	K V
UBS Group	26.83	-3.56 %	K V
ABB	49.34	-4.23 %	K V
Part Grp Hldg	1’215.50	-4.40 %	K V

Nachrichten zu Pfizer Inc.

Aktien Top/Flop

Pfizer Peer Group Nachrichten

Meistgelesene Nachrichten